Overview
- Executive Chairman Joseph Chee said the company aims to acquire up to 5% of the SOL supply, an effort estimated at over $6 billion.
- Holdings now exceed 2.2 million SOL, with about $15 million in cash earmarked for further accumulation.
- The company rebranded from Helius Medical Technologies and says it has support from Pantera Capital and Xia Yan Capital, plus a letter of intent with the Solana Foundation.
- Chee cited Solana’s throughput of over 1,500 transactions per second as a key reason to prefer a SOL-denominated treasury.
- Institutional SOL treasuries have expanded, with DATs reported at 17.8 million SOL in aggregate and recent large programs by Forward Industries and VisionSys AI.